Tag - astrazeneca

 
 

ASTRAZENECA

Japan Times
JAPAN / Science & Health
Aug 7, 2020
Japan and AstraZeneca set for deal on 100 million doses of virus vaccine
The drugmaker is expected to begin clinical trials in Japan later this month to confirm the efficacy and safety of its vaccine, currently being tested overseas.
Japan Times
JAPAN / Science & Health
Aug 1, 2020
Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people
The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Japan Times
JAPAN / Science & Health
May 22, 2020
Japan to subsidize mass production of eventual coronavirus vaccine
More than 110 coronavirus vaccine development projects are underway worldwide, with some in the clinical testing phase, according to a WHO list.
Japan Times
BUSINESS / Companies
Mar 29, 2019
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment
Britain's AstraZeneca's biggest deal in recent memory give it access to the Japanese drugmaker's promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.
Japan Times
JAPAN / Science & Health
Aug 8, 2017
AstraZeneca seeks Japan's first approval for hereditary cancer drug in relapsed sufferers
Olaparib, already approved in the United States and the European Union, acts against cancers in people with hereditary mutations in genes associated with breast and ovarian cancer.
EDITORIALS
May 8, 2013
Lessons from the Iressa case
The Supreme Court upholds rulings that the Japanese unit of British drug maker AstraZeneca PLC is not liable for fatal side effects of the lung cancer drug Iressa.
Japan Times
JAPAN / Crime & Legal
Apr 13, 2013
Top court backs rulings absolving drugmaker's Japan agent over deaths laid to Iressa
The Supreme Court on Friday upheld high court rulings that the Japanese unit of British drugmaker AstraZeneca PLC bore no liability over fatal side effects caused by the lung cancer drug Iressa.

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces